These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26718619)

  • 1. Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
    Honore PM; Spapen HD
    Crit Care; 2015 Dec; 19():455. PubMed ID: 26718619
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Lam S; Gomolin IH
    Pharmacotherapy; 2006 Aug; 26(8):1169-74. PubMed ID: 16863493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime-induced neurotoxicity: a systematic review.
    Payne LE; Gagnon DJ; Riker RR; Seder DB; Glisic EK; Morris JG; Fraser GL
    Crit Care; 2017 Nov; 21(1):276. PubMed ID: 29137682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
    Capparelli FJ; Diaz MF; Hlavnika A; Wainsztein NA; Leiguarda R; Del Castillo ME
    Neurology; 2005 Dec; 65(11):1840. PubMed ID: 16344542
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cefepime-induced encephalopathy in patients with renal failure].
    Martín Herrera C; Navarro M
    Nefrologia; 2009; 29(2):181. PubMed ID: 19396333
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrospective review of neurotoxicity induced by cefepime and ceftazidime.
    Chow KM; Szeto CC; Hui AC; Wong TY; Li PK
    Pharmacotherapy; 2003 Mar; 23(3):369-73. PubMed ID: 12627936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring when using cefepime in continuous renal replacement therapy: seizures associated with cefepime.
    Smith NL; Freebairn RC; Park MA; Wallis SC; Roberts JA; Lipman J
    Crit Care Resusc; 2012 Dec; 14(4):312-5. PubMed ID: 23230881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible coma secondary to cefepime neurotoxicity.
    Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M
    Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe neurotoxicity of cefepime in uremic patients.
    Barbey F; Bugnon D; Wauters JP
    Ann Intern Med; 2001 Dec; 135(11):1011. PubMed ID: 11730416
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Cefepime on Neurotoxicity Development in Critically Ill Adults With Renal Dysfunction.
    Khan A; DeMott JM; Varughese C; Hammond DA
    Chest; 2020 Jul; 158(1):157-163. PubMed ID: 32147247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin/tazobactam-induced neurotoxicity in a hemodialysis patient: a case report.
    Neves PD; Freitas FM; Kojima CA; Carmello BL; Bazan R; Barretti P; Martin LC
    Hemodial Int; 2015 Jan; 19(1):143-5. PubMed ID: 25098503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime-induced neurotoxicity in a patient with coronary artery bypass.
    Shah M; Shah H; Maslekar A
    Indian J Pharmacol; 2016; 48(5):599-600. PubMed ID: 27721551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime neurotoxicity despite renal adjusted dosing.
    Gangireddy VG; Mitchell LC; Coleman T
    Scand J Infect Dis; 2011 Oct; 43(10):827-9. PubMed ID: 21604923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of early haemodialysis in cefepime-induced neurotoxicity.
    Heras M; Parra MA; Macías MC; Azanza JR; Prado F; Sánchez R; Fernández-Reyes MJ
    Nefrologia; 2013; 33(2):273-5. PubMed ID: 23511766
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefepime-induced encephalopathy.
    Dakdouki GK; Al-Awar GN
    Int J Infect Dis; 2004 Jan; 8(1):59-61. PubMed ID: 14690782
    [No Abstract]   [Full Text] [Related]  

  • 18. Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient With Kidney Transplant.
    Balderia PG; Chandorkar A; Kim Y; Patnaik S; Sloan J; Newman GC
    J Patient Saf; 2018 Jun; 14(2):e33-e34. PubMed ID: 26102002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring.
    Grill MF; Maganti R
    Ann Pharmacother; 2008 Dec; 42(12):1843-50. PubMed ID: 19033476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime-induced Neurotoxicity: A Retrospective Cohort Study in a South-Indian Tertiary Healthcare Facility.
    Alijani E; Miraj SS; Kurian SJ; Rao M; Saravu K
    Curr Drug Saf; 2023; 18(1):69-78. PubMed ID: 35264094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.